Aridhia Announces Revolutionary Mini-App Technology to Accelerate Clinical Application Development Following RStudio Collaboration

AridhiaAridhia, the pioneering clinical and translational informatics company, today announced a revolutionary 'mini-app' rapid development solution specifically for clinical applications. The solution integrates the RStudio Shiny web application framework and Shiny Server Pro secure, performant application deployment platform to enhance AnalytiXagility's collaborative workspaces.

All too often the translation of healthcare applications into clinical practice fails due to a breakdown in communication between the data scientists that build analytic models, and the clinical practitioners who consume them.

Chris Roche, CEO at Aridhia, says: "Within one of our collaborative workspaces, any member of a multidisciplinary team, no matter what their role is, will now be able to easily interact with their data - and each other - without the need to understand advanced analytics."

Aridhia's new 'mini-app' rapid prototyping capability embeds RStudio's Shiny reactive data visualisation technology into the company's AnalytiXagility platform, enabling multidisciplinary teams to accelerate the development and deployment of analytically-driven clinical applications.

Data scientists will now be able to rapidly build interactive, visual 'apps', bringing their analysis and data to life, and allowing the rest of their multidisciplinary team to interact with data early in the development lifecycle through an incredible visual experience.

This means for the first time, highly-targeted, prototype healthcare applications can be developed and validated in a matter of hours, rather than weeks.

Roche says: "This morning I asked one of our data scientists to upload a prescribing data set into a workspace. By lunchtime I had several mini-apps in place which I can use to visualise the data in multiple ways at an afternoon meeting. Previously this would have meant several different requests, and a long wait, but now I can interact with the data much more quickly - and without the need for advanced analytic skills."

The healthcare industry is a late and slow adopter of technology, which means that innovations are much slower to disseminate than in other industries. Aridhia believes that a technology-enabled innovation pipeline is critical to facilitating increased collaboration to foster the next generation of patient care innovations, as well as promoting long-term economic growth and healthcare benefits.

Combining the power of R, an advanced analytics language, with modern web technologies, such as Shiny, will allow healthcare and research organisations to exploit the information revolution at a rapid rate.

This is the first time that the Edinburgh-based company Aridhia and RStudio, the Boston company behind free and open source tools for users of the R programming language, have worked together.

The collaboration announcement comes as Aridhia launches the latest version of AnalytiXagility.

"We're absolutely delighted to see how Aridhia has integrated Shiny and Shiny Server Pro into its clinical solution," said Tareef Kawaf, president of RStudio.

"The importance of data science in healthcare is gaining greater awareness. Tools that enable the sharing and understanding of the analytical models to the widest possible audience have become more important than ever before."

"We enjoy seeing what the community can achieve with R," continued Kawaf. "The combination of open technologies which Aridhia has embedded into AnalytiXagility, including R and Shiny, mean that it’s rapidly becoming a crucial component of multidisciplinary, collaborative clinical research and innovation delivery, which can have a significant impact on patient care. We are truly proud to be part of this effort."

This latest version of Aridhia's platform meets two important objectives - delivering a more comprehensive suite of analytic tools to support multidisciplinary research teams, and adding new information governance features that give stakeholders increased control of their data by logging all activity connected to workspaces.

This is Aridhia's first collaboration with RStudio but the latest in a number of pioneering collaborations. Recently, the company announced its partnership with fellow Scottish health tech company Craneware to target the US market, and last year it announced its membership of the Global Alliance for Genomics and Health. Aridhia's data science platform underpins the world-leading Stratified Medicine Scotland Innovation Centre (SMS-IC).

About Aridhia Informatics
Aridhia is a world-leading clinical and translational informatics company developing technology and capability that accelerates the translation of precision medicine and biomedical research into clinical practice. Operating internationally on projects in Australia, England, Scotland and Kuwait, Aridhia works closely with governments, health organisations, research collaborations and academic institutions.

Aridhia was co-founded in 2007 by Dr David Sibbald a software entrepreneur, philanthropist and Vice-President of UK UNICEF, the United Nations children's fund, and Professor Andrew Morris, Chief Scientist for Health in Scotland and Professor of Medicine, Director of the Institute of Population Heath Sciences and Informatics, and Vice-Principal of the University for Data Science at the University of Edinburgh.

Based in Edinburgh and Glasgow, Aridhia has a 60-strong multidisciplinary team of data scientists, information governance specialists, computer scientists, software developers and healthcare experts.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...